SynCore Biotechnology Co.,Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 3.36 million compared to TWD 1.31 million a year ago. Net loss was TWD 42.37 million compared to TWD 71.57 million a year ago. Basic loss per share from continuing operations was TWD 0.37 compared to TWD 0.65 a year ago.